https://chironstem-usa.com/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma/2025-12-23T18:56:03+08:00https://chironstem-usa.com/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma/2025-12-23T18:56:03+08:00https://chironstem-usa.com/pipeline/2025-12-23T19:12:12+08:00